Mechanistically, tRF‐34‐P4R8YP9LON4VHM could downregulate DAB2IP expression by directly targeting its 3'‐UTR, consequently activating the MEK/ERK signalling pathway and promoting the secretion of VEGFA from HCC cells into the supernatant. Here, DAB2IP is linked to hepatocellular carcinoma.